September 22, 2026

Rifan Muazin

Hidden Risks: New Research Links Prior COVID-19 to Increased Blood Clot Danger in Post-Weight Loss Surgery hidden-risks-new-research-links-prior-covid-19-to-increased-blood-clot-danger-in-post-weight-loss-surgery

Hidden Risks: New Research Links Prior COVID-19 to Increased Blood Clot Danger in Post-Weight Loss Surgery

Rifan Muazin July 1, 2026
In the evolving landscape of post-pandemic medicine, surgeons are discovering that the biological footprint of COVID-19 may...
Read More Read more about Hidden Risks: New Research Links Prior COVID-19 to Increased Blood Clot Danger in Post-Weight Loss Surgery
Viatris Reports Promising Phase III Data for VR-205 in Japanese IgAN Patients, Signaling Potential Breakthrough viatris-reports-promising-phase-iii-data-for-vr-205-in-japanese-igan-patients-signaling-potential-breakthrough

Viatris Reports Promising Phase III Data for VR-205 in Japanese IgAN Patients, Signaling Potential Breakthrough

Rifan Muazin June 30, 2026
London, UK – [Insert Date] – Viatris Inc. has announced compelling topline results from a pivotal Phase...
Read More Read more about Viatris Reports Promising Phase III Data for VR-205 in Japanese IgAN Patients, Signaling Potential Breakthrough
Reshaping Global Health: The 79th World Health Assembly Confronts the Future of Pandemic Preparedness reshaping-global-health-the-79th-world-health-assembly-confronts-the-future-of-pandemic-preparedness

Reshaping Global Health: The 79th World Health Assembly Confronts the Future of Pandemic Preparedness

Rifan Muazin June 29, 2026
GENEVA – Under the banner "Reshaping global health: a shared responsibility," the 79th World Health Assembly (WHA)...
Read More Read more about Reshaping Global Health: The 79th World Health Assembly Confronts the Future of Pandemic Preparedness
Absci Secures $100 Million and Advances AI-Designed Therapy for Endometriosis and Hair Loss Following Promising Phase I Data absci-secures-100-million-and-advances-ai-designed-therapy-for-endometriosis-and-hair-loss-following-promising-phase-i-data

Absci Secures $100 Million and Advances AI-Designed Therapy for Endometriosis and Hair Loss Following Promising Phase I Data

Rifan Muazin June 28, 2026
San Francisco, CA – [Insert Date] – Absci Corporation, a pioneering biotechnology company leveraging artificial intelligence (AI)...
Read More Read more about Absci Secures $100 Million and Advances AI-Designed Therapy for Endometriosis and Hair Loss Following Promising Phase I Data
The Intersection of Advocacy and Survival: Alexis Fish’s Journey Through Triple-Positive Breast Cancer and the Power of Community Support the-intersection-of-advocacy-and-survival-alexis-fishs-journey-through-triple-positive-breast-cancer-and-the-power-of-community-support

The Intersection of Advocacy and Survival: Alexis Fish’s Journey Through Triple-Positive Breast Cancer and the Power of Community Support

Rifan Muazin June 28, 2026
LOS ANGELES, CA — As the calendar turned to June 2026, marking the beginning of Pride Month,...
Read More Read more about The Intersection of Advocacy and Survival: Alexis Fish’s Journey Through Triple-Positive Breast Cancer and the Power of Community Support
Ascletis Pharma Secures FDA Clearance for Promising Obesity Drug ASC35, Pioneering Once-Monthly Subcutaneous Delivery ascletis-pharma-secures-fda-clearance-for-promising-obesity-drug-asc35-pioneering-once-monthly-subcutaneous-delivery

Ascletis Pharma Secures FDA Clearance for Promising Obesity Drug ASC35, Pioneering Once-Monthly Subcutaneous Delivery

Rifan Muazin June 25, 2026
Cambridge, MA – [Insert Date] – Ascletis Pharma Inc. has announced a significant advancement in its pursuit...
Read More Read more about Ascletis Pharma Secures FDA Clearance for Promising Obesity Drug ASC35, Pioneering Once-Monthly Subcutaneous Delivery

You may have missed

the-quiet-evolution-why-yogas-decline-is-actually-a-return-to-form

The Quiet Evolution: Why Yoga’s "Decline" Is Actually a Return to Form

Muslim September 22, 2026
beyond-the-surface-the-critical-science-of-early-wound-assessment-and-microbial-identification

Beyond the Surface: The Critical Science of Early Wound Assessment and Microbial Identification

Siti Muinah September 22, 2026
cardiacare-secures-oversubscribed-funding-to-pioneer-non-invasive-wearable-therapy-for-atrial-fibrillation

CardiaCare Secures Oversubscribed Funding to Pioneer Non-Invasive Wearable Therapy for Atrial Fibrillation

Muslim September 22, 2026
bridging-the-gap-in-survivorship-health-canada-authorizes-non-hormonal-treatment-for-breast-cancer-therapy-side-effects

Bridging the Gap in Survivorship: Health Canada Authorizes Non-Hormonal Treatment for Breast Cancer Therapy Side Effects

Iffa Jayyana September 22, 2026